1)traumatic proliferative vitreoretinopathy外伤性增殖性玻璃体视网膜病变
1.AIM: To investigate whether telomerase catalytic sub-unit (TERT) takes part in the regulation of cell proliferation in epiretinal membranes in traumatic proliferative vitreoretinopathy (PVR) and its dynamic change.目的:探讨端粒酶催化亚单位(TERT)是否参与了实验性外伤性增殖性玻璃体视网膜病变(PVR)视网膜前膜的细胞增殖调控及其随病程的动态变化。
2.[Objective] To analyze the pathology of traumatic proliferative vitreoretinopathy(TPVR)by using proliferating cell nuclear antigen(PCNA)as a mark to observe the proliferative course during the development of experimental traumatic proliferative vitreoretinopathy(TPVR)and study the risk factors,the initial points and the roles of different cells in the formation of TPVR.[目的]观察实验性外伤性增殖性玻璃体视网膜病变(traumatic proliferative vitreoretinopathy TPVR)的病理过程,以增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)为细胞增殖指标,探讨TPVR的危险因素、增殖起点及各种增殖细胞的作用。
2)traumatic proliferative vitreoretinopathy外伤性增生性玻璃体视网膜病变
1.Research on the intervention of TIMPs-GM6001 in the traumatic proliferative vitreoretinopathy;基质金属蛋白酶抑制剂GM6001干预外伤性增生性玻璃体视网膜病变的研究
2.Study on pathomorphology of traumatic proliferative vitreoretinopathy after GM 6001 interventionGM 6001干预外伤性增生性玻璃体视网膜病变的病理形态学研究
3.Objective To study the curative and preventive effects of SanXueMingMu tablet on traumatic proliferative vitreoretinopathy(tPVR)in rabbits.目的探讨活血利水之散血明目片对外伤性增生性玻璃体视网膜病变(traumaticproliferativevitreoretinopathy,tPVR)玻璃体中碱性成纤维细胞生长因子(basicfibroblastsgrowthfactors,bFGF)、表皮生长因子(epidermalgrowthfactor,EGF)和细胞间粘附分子1(intercellularadhesionmolecule1,ICAM1)浓度的影响及防治PVR的作用机理。
traumatic proliferative vitreoretinopathy外伤性增生性玻璃体视网膜病变
1.Research on the intervention of TIMPs-GM6001 in the traumatic proliferative vitreoretinopathy;基质金属蛋白酶抑制剂GM6001干预外伤性增生性玻璃体视网膜病变的研究
2.Study on pathomorphology of traumatic proliferative vitreoretinopathy after GM 6001 interventionGM 6001干预外伤性增生性玻璃体视网膜病变的病理形态学研究
3.Objective To study the curative and preventive effects of SanXueMingMu tablet on traumatic proliferative vitreoretinopathy(tPVR)in rabbits.目的探讨活血利水之散血明目片对外伤性增生性玻璃体视网膜病变(traumaticproliferativevitreoretinopathy,tPVR)玻璃体中碱性成纤维细胞生长因子(basicfibroblastsgrowthfactors,bFGF)、表皮生长因子(epidermalgrowthfactor,EGF)和细胞间粘附分子1(intercellularadhesionmolecule1,ICAM1)浓度的影响及防治PVR的作用机理。
3)proliferative vitreoretinopathy/surgery增殖性玻璃体视网膜病变/外科手术
4)Proliferative vetreoretinopathy增殖性玻璃体视网膜病
5)proliferative vitreoretinopathy增殖性玻璃体视网膜病变
1.Electroretinogram of 5-fluorouracil and LMWH prevention of proliferative vitreoretinopathy;氟尿嘧啶联合低分子肝素预防增殖性玻璃体视网膜病变的视网膜电图
2.Preparing retinoic acid nanosuspensions and preventing experimental proliferative vitreoretinopathy;维甲酸纳米颗粒混悬剂的制备及对实验性增殖性玻璃体视网膜病变的预防作用
3.Effects of intravitreal administration of triamcinolone acetonide on postoperative proliferative vitreoretinopathy;曲安奈德预防术后增殖性玻璃体视网膜病变临床观察
6)proliferative vitreoretinopathy/chemically induced增殖性玻璃体视网膜病变/化学诱导
延伸阅读
性幼稚-色素性视网膜炎-多指畸形综合征性幼稚-色素性视网膜炎-多指畸形综合征 病名。亦称劳-穆-比综合征。其临床特点为肥胖、性腺发育不良、智力低下、色素性视网膜炎、多指或并指畸形以及其他先天性异常等。 早在1866年由Laurence等首先报道。其性腺发育不良表现为阴茎小、睾丸不发育、 外生殖器呈幼稚型、阴囊有时分裂，以及青春期不出现第二性征等。部分可出现各 种类型先天性心脏病、肾脏的先天异常、神经系统的先天异常、骨骼系统的先天 性异常，以及颜面的先天性异常等。血、尿中促性腺激素明显降低，睾酮亦明显低下 ，尿中17-酮类固醇含量亦低于正常。睾丸活检可见曲细精管结构基本正常，但缺乏精子形成。间质细胞亦未见异常改变。多有阳性家族史，染色体组型正常。属常染色体隐性遗传性疾病。无特殊治疗方法。针对睾丸功能低下可进行性激素治疗。
